Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiaki Iba

Showing results (21-30 of 274) with videos related to

Pageof 28
Sort By:
Juntendo Iji Zasshi = Juntendo Medical Journal|October 21, 2024
Mitochondrial Damage in SepsisRicard Ferrer, Toshiaki Iba
Critical Care (London, England)|July 8, 2008
Danaparoid sodium attenuates the increase in inflammatory cytokines and preserves organ function in endotoxemic ratsToshiaki Iba, Taku Miyasho
Journal of Intensive Care|February 24, 2015
Efficacy of antithrombin in preclinical and clinical applications for sepsis-associated disseminated intravascular coagulationToshiaki Iba, Daizoh Saitoh
Critical Care Medicine|July 17, 2014
Is postoperative polymyxin B hemoperfusion for abdominal septic shock really ineffective?Naoyuki Hashiguchi, Toshiaki Iba
Intensive Care Medicine|May 5, 2016
Is antithrombin III for sepsis-associated disseminated intravascular coagulation really ineffective?Toshiaki Iba, Jecko Thachil
Internal and Emergency Medicine|December 28, 2020
COVID-19 coagulopathy: is it disseminated intravascular coagulation?Marcel Levi, Toshiaki Iba
Intensive Care Medicine|November 9, 2016
Is protein C zymogen really ineffective for ALL cases of sepsis including septic DIC?Toshiaki Iba, Jecko Thachil
Juntendo Iji Zasshi = Juntendo Medical Journal|October 21, 2024
The Effect of Antiplatelet Therapy on COVID-19Ecaterina Scarlatescu, Toshiaki Iba
Journal of Intensive Care|November 1, 2018
Role of extracellular vesicles in the development of sepsis-induced coagulopathyToshiaki Iba, Hiroshi Ogura
Shock (Augusta, Ga.)|November 17, 2004
What can we learn from the three megatrials using anticoagulants in severe sepsis?Toshiaki Iba, Akio Kidokoro
Pageof 28

Showing results (21-30 of 274) with videos related to

Sort By:
Pageof 28
Juntendo Iji Zasshi = Juntendo Medical Journal|October 21, 2024
Mitochondrial Damage in SepsisRicard Ferrer, Toshiaki Iba
Critical Care (London, England)|July 8, 2008
Danaparoid sodium attenuates the increase in inflammatory cytokines and preserves organ function in endotoxemic ratsToshiaki Iba, Taku Miyasho
Journal of Intensive Care|February 24, 2015
Efficacy of antithrombin in preclinical and clinical applications for sepsis-associated disseminated intravascular coagulationToshiaki Iba, Daizoh Saitoh
Critical Care Medicine|July 17, 2014
Is postoperative polymyxin B hemoperfusion for abdominal septic shock really ineffective?Naoyuki Hashiguchi, Toshiaki Iba
Intensive Care Medicine|May 5, 2016
Is antithrombin III for sepsis-associated disseminated intravascular coagulation really ineffective?Toshiaki Iba, Jecko Thachil
Internal and Emergency Medicine|December 28, 2020
COVID-19 coagulopathy: is it disseminated intravascular coagulation?Marcel Levi, Toshiaki Iba
Intensive Care Medicine|November 9, 2016
Is protein C zymogen really ineffective for ALL cases of sepsis including septic DIC?Toshiaki Iba, Jecko Thachil
Juntendo Iji Zasshi = Juntendo Medical Journal|October 21, 2024
The Effect of Antiplatelet Therapy on COVID-19Ecaterina Scarlatescu, Toshiaki Iba
Journal of Intensive Care|November 1, 2018
Role of extracellular vesicles in the development of sepsis-induced coagulopathyToshiaki Iba, Hiroshi Ogura
Shock (Augusta, Ga.)|November 17, 2004
What can we learn from the three megatrials using anticoagulants in severe sepsis?Toshiaki Iba, Akio Kidokoro
Pageof 28